Yael Cohen

23PUBLICATIONS
77CO-AUTHORS
Medical mycologyHaematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Gene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Feb 27, 2026
Surveillance of Smoldering Myeloma Patients Who Progress to Active Disease Is Associated with Favorable Outcomes.

Gil Fridberg, Inbar Cohen, Renana Robinson

|Dec 30, 2025
Extramedullary Disease-Achilles Heel in Myeloma?

Shaji Kumar, Joshua Richter, Saad Z Usmani

|May 15, 2025
Correction: Preclinical discovery and initial clinical data of WVT078, a BCMA × CD3 bispecific antibody.

Marc S Raab, Yael C Cohen, Fredrik Schjesvold

|Feb 13, 2025
Author Correction: Daratumumab plus bortezomib, lenalidomide and dexamethasone for transplant-ineligible or transplant-deferred newly diagnosed multiple myeloma: the randomized phase 3 CEPHEUS trial.

Saad Z Usmani, Thierry Facon, Vania Hungria

|Feb 05, 2025
Daratumumab plus bortezomib, lenalidomide and dexamethasone for transplant-ineligible or transplant-deferred newly diagnosed multiple myeloma: the randomized phase 3 CEPHEUS trial.

Saad Z Usmani, Thierry Facon, Vania Hungria

|Apr 06, 2023
Preclinical discovery and initial clinical data of WVT078, a BCMA × CD3 bispecific antibody.

Marc S Raab, Yael C Cohen, Fredrik Schjesvold

Pageof 4

Frequent Collaborators

6 joint publications

Irit Avivi

5 joint publications

Moshe Gatt

5 joint publications

Chezi Ganzel

3 joint publications

Tamir Shragai